EUVIMEDEUVIMED entdecken
Open Access

The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible

Nicholas O Stevers, Somang Kim, Jimmy Bo Yuan, Carter J Barger, Chibo Hong, Olivia Lenzo, Andrew M McKinney, Samuel H Wu, Yu Jin Lee, Darwin W Kwok, Abigail K Suwala, Christina L Appin und 4 weitere

Molecular Cell · 2025-06 · 85 (12) · 2337-2354.e9

DOI: 10.1016/j.molcel.2025.05.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2025-06. Verfasst von Nicholas O Stevers und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Telomerase, Promoter Regions, Genetic, GA-Binding Protein Transcription Factor, Mutation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activating mutations in the telomerase reverse transcriptase (TERT) promoter are prevalent in cancer and enable limitless cell division characteristic of immortal cells. Solving the immortality mechanism represents a major step toward selective reversal in cancer cells. TERT promoter (TERTp) mutations create a de novo E26 transformation-specific (ETS) transcription factor binding motif. Here, we analyzed 53 cell lines representing 16 cancer types and 6 recurrent TERTp mutations and found that the GA-binding protein (GABP) tetramer is responsible for promoter activation in all cases. Surprisingly, TERT expression is maintained after tetramer depletion. Further investigation revealed an underlying network of auto-suppression among the GABP subunits. Release from it drives TERT maintenance via upregulated GABP dimers or a paralogous tetramer. The GABPB1L tetramer is therefore a pan-cancer, pan-mutation activator of the mutant TERT promoter, but it is replaceable. Domains shared by the three GABP complexes, rather than solely the B1L tetramer, are mutation-specific vulnerabilities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomerasePromoter Regions, GeneticGA-Binding Protein Transcription FactorMutationNeoplasmsCell Transformation, NeoplasticHumansCell Line, TumorGene Expression Regulation, NeoplasticProtein MultimerizationBinding Sites

Stichwörter der Autor:innen

GABPTERT promoter mutationnoncoding mutationpan-cancertelomeretumor immortality

Substanzen

TelomeraseTERT protein, humanGA-Binding Protein Transcription FactorGABPB1 protein, human

Autor:innen und Institutionen

  • Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA.
  • Department of Physics, University of Illinois, Urbana-Champaign, Champaign, IL, USA; Institute for Genomic Biology, University of Illinois, Urbana-Champaign, Champaign, IL, USA; Cancer Center at Illinois, University of…
  • Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA, USA; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San…
  • Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA. Electronic address: joseph.costello@ucsf.edu.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health National Cancer Institute
  • NIH National Institute of General Medical Sciences

Zitieren

APA

Stevers, N. O., Kim, S., Yuan, J. B., Barger, C. J., Hong, C., Lenzo, O., McKinney, A. M., Wu, S. H., Lee, Y. J., Kwok, D. W., Suwala, A. K., Appin, C. L., Gordan, J. D., Molinaro, A. M., Song, J. S., & Costello, J. F. (2025). The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible. Molecular Cell, 85(12), 2337-2354.e9. https://doi.org/10.1016/j.molcel.2025.05.026

Vancouver

Stevers NO, Kim S, Yuan JB, Barger CJ, Hong C, Lenzo O, et al. The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible. Molecular Cell. 2025;85(12):2337-2354.e9. doi:10.1016/j.molcel.2025.05.026

BibTeX
@article{Stevers2025,
  author = {Stevers, Nicholas O and Kim, Somang and Yuan, Jimmy Bo and Barger, Carter J and Hong, Chibo and Lenzo, Olivia and McKinney, Andrew M and Wu, Samuel H and Lee, Yu Jin and Kwok, Darwin W and Suwala, Abigail K and Appin, Christina L and Gordan, John D and Molinaro, Annette M and Song, Jun S and Costello, Joseph F},
  title = {The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible},
  journal = {Molecular Cell},
  year = {2025},
  volume = {85},
  number = {12},
  pages = {2337--2354.e9},
  doi = {10.1016/j.molcel.2025.05.026}
}
Kostenlos starten →